LGND logo

LGND

Profile

Full Name

Ligand Pharmaceuticals Incorporated

Ticker Symbol

LGND

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

November 18, 1992

Indexes

Not included

Website

http://www.ligand.com

Employees

68

Key Details

Price

$106.80(+0.20%)

Market cap

$2.06B(Mid cap)

Last Dividend

$0.46

TTM Dividend yield

-

Annual revenue

$167.13M(+27.28% YoY)

Annual EPS

-$0.22(-107.48% YoY)

PE ratio

-

Next earnings date

May 7, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$106.80
LGND price is $106.80

30-Day Relative Volume

0.45
LGND 30-day relative volume is 0.45

Price Performance

Price Most recent change

+0.2%
LGND price was up +0.2% on Apr 15, 2025

Price YTD change

-0.33%
LGND price is down -0.33% since January 1st

Price 1-year change

+33.63%
LGND price is up +33.63% year-on-year

Price 3-year change

+1.46%
LGND price is up +1.46% over the past 3 years

Price Range

Price All-time high

$274.49
LGND price is currently -61.09% below its historical high of $274.49

Price 3-year low

$45.27
LGND price is currently +135.91% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$2.06B
LGND market capitalization is $2.06 billion

Market cap 3-year change

+15.87%
LGND market capitalization is up +15.87% over the past 3 years

Market cap All-time high

$5.79B
LGND market capitalization is currently -64.50% below its historical high of $5.79 billion

Market cap sector rank

83.55%
LGND market capitalization is higher than 83.55% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+7.43%
LGND shares outstanding is up +7.43% year-on-year

Shares Outstanding 3-Year Change

+14.2%
LGND shares outstanding is up +14.2% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

1.04
LGND beta is 1.04

200-day SMA

$108.41
LGND price is currently -1.48% below its 200-day simple moving average

50-day SMA

$111.01
LGND price is currently -3.79% below its 50-day simple moving average

RSI

50.37
LGND 14-day relative strength index is 50.37

Volume

0.45
LGND 30-day relative volume is 0.45

ATR

$5.60
LGND average true range is $5.60

10-day Historical Volatility

61.33%
LGND 10-day historical volatility is 61.33%

Dividend

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Events

Last Paid Dividend

$0.46
LGND last dividend was $0.46 per share, with an ex-dividend date of July 2, 2010

Next Dividend

-
LGND next dividend has not yet been announced

Dividend per share

Dividend per share

-
LGND annual dividend per share value is unknown

Dividend per share Sector Rank

-
LGND annual dividend per share is unknown

Dividend per share 1-Year Change

-
LGND annual dividend per share 1-year change is unknown

Dividend per share 3-Year Change

-
LGND annual dividend per share 3-year change is unknown

Dividend yield

Dividend yield

-
LGND annual dividend yield value is unknown

Dividend yield Sector Rank

-
LGND annual dividend yield is unknown

Other

Payout ratio

-
LGND annual payout ratio value is unknown

Dividends paid

-
LGND annual dividends paid value is unknown

Free cash flow

$77.41M
LGND annual free cash flow is $77.41 million

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$167.13M
LGND annual revenue is $167.13 million

Revenue Analysts estimate

$191.30M
LGND annual revenue is currently -12.63% lower than the consensus analysts' forecast

Revenue 1-year change

+27.28%
LGND annual revenue is up +27.28% year-on-year

Revenue Sector rank

61.45%
LGND annual revenue is higher than 61.45% of companies in Healthcare sector

EPS

EPS

-$0.22
LGND annual earnings per share is -$0.22

EPS Analysts estimate

$6.11
LGND annual earnings per share is currently -103.60% lower than the consensus analysts' forecast

EPS 1-year change

-107.48%
LGND annual earnings per share is down -107.48% year-on-year

EPS Sector rank

77.13%
LGND annual earnings per share is higher than 77.13% of companies in Healthcare sector

Profit

Gross profit

$156.06M
LGND annual gross profit is $156.06 million

Gross margin

93.37%
LGND annual gross profit margin is 93.37%

Operating profit

$23.02M
LGND annual operating income is $23.02 million

Operating margin

13.77%
LGND annual operating profit margin is 13.77%

Net income

-$4.03M
LGND annual net profit is -$4.03 million

Net margin

-2.41%
LGND annual net profit margin is -2.41%

Expenses

Total expenses

$144.11M
LGND annual total expenses is $144.11 million

Operating expenses

$133.04M
LGND annual total operating expenses is $133.04 million

Cost of goods sold

$11.07M
LGND annual cost of goods sold is $11.07 million

Selling, general & administrative expenses

$78.65M
LGND annual SGA is $78.65 million

Depreciation and amortization

$35.24M
LGND annual depreciation & amortization is $35.24 million

Interest expense

$3.04M
LGND annual interest expense is $3.04 million

Income tax

$6.55M
LGND annual income tax is $6.55 million

EBIT & EBITDA

EBIT

$5.55M
LGND annual earnings before interest & taxes is $5.55 million

EBITDA

$40.79M
LGND annual EBITDA is $40.79 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$941.77M
LGND annual total assets is $941.77 million

Non current assets

$610.22M
LGND annual long term assets is $610.22 million

Current assets

$331.56M
LGND annual total current assets is $331.56 million

Cash and cash equivalents

$72.31M
LGND annual cash & cash equivalents is $72.31 million

Accounts receivable

$38.38M
LGND annual accounts receivable is $38.38 million

Inventory

$14.11M
LGND annual inventory is $14.11 million

Liabilities

Total liabilities

$111.33M
LGND annual total liabilities is $111.33 million

Long term liabilities

$74.22M
LGND annual total long term liabilities is $74.22 million

Current liabilities

$37.11M
LGND annual total current liabilities is $37.11 million

Accounts payable

$5.23M
LGND annual accounts payable is $5.23 million

Debt

Total debt

$7.11M
LGND annual total debt is $7.11 million

Total debt 1-year change

+15.25%
LGND annual total debt is up +15.25% year-on-year

Long term debt

$5.82M
LGND annual long term debt is $5.82 million

Short term debt

$1.29M
LGND annual short term debt is $1.29 million

Equity & Capital

Shareholders equity

$830.44M
LGND annual stockholders equity is $830.44 million

Book value

$830.44M
LGND annual book value is $830.44 million

Retained earnings

$498.98M
LGND annual retained earnings is $498.98 million

Working capital

$294.45M
LGND annual working capital is $294.45 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

$97.05M
LGND annual cash flow from operations is $97.05 million

Cash from operations 1-year change

+95.75%
LGND annual cash flow from operations is up +95.75% year-on-year

Cash from investing

-$143.66M
LGND annual cash flow from investing activities is -$143.66 million

Cash from investing 1-year change

-1129.79%
LGND annual cash flow from investing activities is down -1129.79% year-on-year

Cash from financing

$97.14M
LGND annual cash flow from financing activities is $97.14 million

Cash from financing 1-year change

+262.04%
LGND annual cash flow from financing activities is up +262.04% year-on-year

CAPEX

CAPEX

$19.64M
LGND annual capital expenditures is $19.64 million

CAPEX 1-year change

-63.53%
LGND annual capital expenditures is down -63.53% year-on-year

Free Cash Flow

Free cash flow

$77.41M
LGND annual free cash flow is $77.41 million

Free cash flow 1-year change

+1911.96%
LGND annual free cash flow is up +1911.96% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

93.37%
LGND annual gross profit margin is 93.37%

Operating margin

13.77%
LGND annual operating profit margin is 13.77%

Net margin

-2.41%
LGND annual net profit margin is -2.41%

ROA & ROE

ROA

-0.47%
LGND annual return on assets is -0.47%

ROE

-0.53%
LGND annual return on equity is -0.53%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
LGND price to earnings ratio value is unknown

PE ratio Sector rank

-
LGND price to earnings ratio is unknown

PB Ratio

PB ratio

2.48
LGND price to book ratio is 2.48

PB ratio Sector rank

68.4%
LGND price to book ratio is higher than 68.4% of companies in Healthcare sector

PS Ratio

PS ratio

12.30
LGND price to sales ratio is 12.30

PS ratio Sector rank

81.79%
LGND price to sales ratio is higher than 81.79% of companies in Healthcare sector

Enterprise value

Enterprise value

$1.99B
LGND enterprise value is $1.99 billion

Enterprise value Sector rank

82.13%
LGND enterprise value is higher than 82.13% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

24.76
LGND EV/EBITDA is 24.76

EV/EBITDA Sector rank

93.39%
LGND EV/EBITDA is higher than 93.39% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

8.93
LGND annual current ratio is 8.93

Quick ratio

8.55
LGND annual quick ratio is 8.55

Leverage

Debt to equity

0.00
LGND annual debt to equity ratio is 0.00

Interest coverage ratio

1.83
LGND annual interest coverage ratio is 1.83

Risk & Stability

Piotroski F-Score

3
LGND piotroski f-score is 3

Altman Z-Score

12.40
LGND altman z-score is 12.40

Analyst ratings

Recent major analysts updates

Apr 10, 25 Stifel
Buy
Dec 23, 24 Benchmark
Buy
Dec 16, 24 Barclays
Overweight
Dec 11, 24 RBC Capital
Outperform
Dec 11, 24 HC Wainwright & Co.
Buy
Nov 12, 24 RBC Capital
Outperform
Nov 8, 24 Oppenheimer
Outperform
Nov 8, 24 HC Wainwright & Co.
Buy
Nov 8, 24 Benchmark
Buy
Nov 8, 24 Barclays
Overweight

Institutional Ownership

Similar stocks

VCEL logo
Vericel (VCEL)
SEM logo
Select Medical Holdings (SEM)
FOLD logo
Amicus Therapeutics (FOLD)
DNLI logo
Denali Therapeutics (DNLI)
LMAT logo
LeMaitre Vascular (LMAT)
APGE logo
Apogee Therapeutics (APGE)
Belite Bio (BLTE)
CLOV logo
Clover Health Investments (CLOV)
BHVN logo
Biohaven (BHVN)
  • What is the ticker symbol for Ligand Pharmaceuticals Incorporated?
  • Does Ligand Pharmaceuticals Incorporated pay dividends?
  • What sector is Ligand Pharmaceuticals Incorporated in?
  • What industry is Ligand Pharmaceuticals Incorporated in?
  • What country is Ligand Pharmaceuticals Incorporated based in?
  • When did Ligand Pharmaceuticals Incorporated go public?
  • Is Ligand Pharmaceuticals Incorporated in the S&P 500?
  • Is Ligand Pharmaceuticals Incorporated in the NASDAQ 100?
  • Is Ligand Pharmaceuticals Incorporated in the Dow Jones?
  • When was Ligand Pharmaceuticals Incorporated's last earnings report?
  • When does Ligand Pharmaceuticals Incorporated report earnings?
  • Should I buy Ligand Pharmaceuticals Incorporated stock now?

What is the ticker symbol for Ligand Pharmaceuticals Incorporated?

The ticker symbol for Ligand Pharmaceuticals Incorporated is NASDAQ:LGND

Does Ligand Pharmaceuticals Incorporated pay dividends?

No, Ligand Pharmaceuticals Incorporated does not pay dividends

What sector is Ligand Pharmaceuticals Incorporated in?

Ligand Pharmaceuticals Incorporated is in the Healthcare sector

What industry is Ligand Pharmaceuticals Incorporated in?

Ligand Pharmaceuticals Incorporated is in the Biotechnology industry

What country is Ligand Pharmaceuticals Incorporated based in?

Ligand Pharmaceuticals Incorporated is headquartered in United States

When did Ligand Pharmaceuticals Incorporated go public?

Ligand Pharmaceuticals Incorporated's initial public offering (IPO) was on November 18, 1992

Is Ligand Pharmaceuticals Incorporated in the S&P 500?

No, Ligand Pharmaceuticals Incorporated is not included in the S&P 500 index

Is Ligand Pharmaceuticals Incorporated in the NASDAQ 100?

No, Ligand Pharmaceuticals Incorporated is not included in the NASDAQ 100 index

Is Ligand Pharmaceuticals Incorporated in the Dow Jones?

No, Ligand Pharmaceuticals Incorporated is not included in the Dow Jones index

When was Ligand Pharmaceuticals Incorporated's last earnings report?

Ligand Pharmaceuticals Incorporated's most recent earnings report was on Feb 27, 2025

When does Ligand Pharmaceuticals Incorporated report earnings?

The next expected earnings date for Ligand Pharmaceuticals Incorporated is May 7, 2025

Should I buy Ligand Pharmaceuticals Incorporated stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page